Category: Drug Side Effects
Actos Prostate Cancer Class Action Lawsuit
Actos Side Effects May Increase Risk of Prostate Cancer: JAMA Study Just months after Takeda Pharmaceuticals agreed to settle thousands of Actos bladder cancer lawsuits, a new study funded by the company appears to indicate that use of the type...
Actos Pancreatic Cancer Class Action Lawsuit
What’s the Problem? The study, which was published July 21 in the Journal of the American medical Association (JAMA), analyzed data from nearly 200,000 patients with type 2 diabetes and found no correlation between Actos and bladder cancer (a disease...
Pradaxa Bleeding Class Action Lawsuit
What’s the Problem? Plaintiffs Michael and Debra Weddle filed the class action in BC Supreme Court on June 30. According to the complaint, Michael Weddle was prescribed Pradaxa in 2010 for a cardiac arrhythmia, and in November 2012 was hospitalized...
Kombiglyze Class Action Lawsuit
Update: DPP-4 Inhibitors Linked to Rhabdomyolysis December 1, 2017 – Diabetes patients who took DPP-4 inhibitors like Kombiglyze XR have been diagnosed with a rare muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...
Onglyza Class Action Lawsuit
Update: Onglyza Heart Failure Lawsuits Centralized in Kentucky February 5, 2018 – JPML has voted to consolidate all federal lawsuits alleging heart failure injuries from Onglyza and Kombiglyze XR for pretrial handling in the Eastern District of Kentucky. The Panel...
Invokana Kidney Failure Class Action Lawsuit
Update: Invokana Kidney Failure Lawsuit Filed in New Jersey May 1, 2017 – A New Jersey woman who allegedly developed an acute kidney injury that led to end-stage renal disease (kidney failure) less than 2 months after taking Invokana for...
Invokana Heart Attack Class Action Lawsuit
Recent studies have linked the type 2 diabetes medication Invokana to cardiovascular side effects including blood clots that could lead to a heart attack. Free Invokana Class Action Lawsuit Evaluation: If you or a loved one was injured by Invokana,...
Xigduo XR Class Action Lawsuit
Update: Xigduo XR Litigation Centralized in New York April 13, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all federal lawsuits involving Farxiga and Xigduo XR be centralized for pretrial handling in the Southern District...
Glyxambi Class Action Lawsuit
Glyxambi may be Linked to Rhabdomyolysis, FDA Warns December 1, 2017 – The U.S. Food & Drug Administration (FDA) is investigating a potential link between Glyxambi and other type 2 diabetes medications in its class and a severe muscular condition...
Invokamet Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokamet May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...